Transcription factor AP-2α is preferentially cleaved by caspase 6 and degraded by proteasome during tumor necrosis factor alpha-induced apoptosis in breast cancer cells

Molecular and Cellular Biology

Volumn 21, Issue 15, 2001, Pages 4856-4867

  Nyormoi, O ^a   Wang, Z ^a   Doan, D ^a   Ruiz, M ^a   McConkey, D ^a   Bar Eli, M ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 6; CASPASE INHIBITOR; DNA FRAGMENT; GREEN FLUORESCENT PROTEIN; PROTEASOME; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR AP 2ALPHA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DNA BINDING; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

AMINO ACID CHLOROMETHYL KETONES; AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; BASE SEQUENCE; BLOTTING, WESTERN; BREAST NEOPLASMS; CASPASE 6; CASPASES; CELL DEATH; CYSTEINE ENDOPEPTIDASES; DNA; DNA FRAGMENTATION; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ENZYME INHIBITORS; FLOW CYTOMETRY; GREEN FLUORESCENT PROTEINS; HUMANS; IN SITU NICK-END LABELING; LUMINESCENT PROTEINS; MOLECULAR SEQUENCE DATA; MULTIENZYME COMPLEXES; MUTAGENESIS, SITE-DIRECTED; MUTATION; PEPTIDES; PROTEASOME ENDOPEPTIDASE COMPLEX; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA PROCESSING, POST-TRANSCRIPTIONAL; TIME FACTORS; TRANSCRIPTION FACTOR AP-2; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

VERTEBRATA;

EID: 0034954558     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.21.15.4856-4867.2001     Document Type: Article

References (77)

1. Molecular mechanisms of melanoma metastasis
2. Role of AP-2 in tumor growth and metastasis of human melanoma
3. Phosphorylation of IκB-α inhibits its cleavage by caspase CPP32 in vitro
4. Opposite transcriptional activity between the wild type c-myc gene coding for c-Myc1 and c-Myc2 proteins and c-Myc1 and c-Myc2 separately
5. RB and c-Myc activate expression of the E-cadherin gene in epithelial cells through interaction with transcription factor AP-2
6. Expression of MXI1, a Myc antagonist, is regulated by Sp1 and AP2
7. The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma
8. An alternatively spliced mRNA from the AP-2 gene encodes a negative regulator of transcriptional activation by AP-2
9. The N-end rule pathway controls the import of peptides through degradation of a transcriptional repressor
10. Programming gene expression in developing epidermis
11. Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis
12. Caspase and calpain substrates: Roles in synaptic plasticity and cell death
13. Proteolytic cleavage of the mdm2 oncoprotein during apoptosis
14. Caspase-mediated cleavage and functional changes of hematopoietic progenitor kinase 1 (HPK1)
15. Caspases: The executioners of apoptosis
16. Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1
17. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei
18. Apoptosis induced by the nuclear death domain protein p84N5 is associated with caspasc-6 and NF-[kappa]B activation
19. Transcription factor AP-2 regulates human insulin-like growth factor binding protein-5 gene expression
20. Mammalian caspases: Structure, activation, substrates, and functions during apoptosis
21. The viral nucleocapsid protein of transmissible gastroenteritis coronavirus (TGEV) is cleaved by caspase-6 and -7 during TGEV-induced apoptosis
22. Transcription factor AP-2 activity is modulated by protein kinase A-mediated phosphorylation
23. Transcriptional activation by Myc is under negative control by the transcription factor AP-2
24. Localization of the gene for the DNA-binding protein AP-2 to human chromosome 6p22.3-pter
25. Immunohistochemical analysis reveals a tumour suppressor-like role for the transcription factor AP-2 in invasive breast cancer
26. Prognostic significance of HER2 and HER4 co-expression in childhood medulloblastoma
27. Activation of transcription factor AP-2 mediates UVA radiation- and singlet oxygen-induced expression of the human intercellular adhesion molecule 1 gene
28. Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis
29. A novel transcription factor, OB2-1 is required for overexpression of the protooncogene c-erbB-2 in mammary tumor lines
30. Redox modulation of AP-2 DNA binding activity in vitro
31. Transcription factor AP-2 mRNA and DNA binding activity are constitutively expressed in SV40-immortalized but not normal human lung fibroblasts
32. Transcription factor AP-2 mediates induction by two different signal-transduction pathways: Protein kinase C and cAMP
33. Transcriptional regulation of the AP-2α promoter by BTEB-1 and AP-2rep, a novel wt-1/egr-related zinc finger repressor
34. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis
35. Loss of AP-2 results in up-regulation of MCAM/MUC18 and an increase in tumor growth and metastasis of human melanoma cells
36. CREB and its associated proteins act as survival factors for human melanoma cells
37. Coactivator PC4 mediates AP-2 transcriptional activity and suppresses ras-induced transformation dependent on AP-2 transcriptional interference
38. PolyADP-ribose polymerase is a coactivator for AP-2-mediated transcriptional activation
39. N-ras oncogene causes AP-2 transcriptional self-interference, which leads to transformation
40. Downregulation of transcription factor AP-2 predicts poor survival in stage I cutaneous malignant melanoma
41. STAT1 is inactivated by a caspase
42. Regulation of transcription factor AP-2 by the morphogen retinoic acid and by second messengers
43. Alternative mRNA encode multiple isoforms of transcription factor AP-2 during murine embryogenesis
44. Characterization of caspase processing and activation in HL-60 cell cytosol under cell-free conditions. Nucleotide requirement and inhibitor profile
45. Positive and negative regulation of transcription in vitro: Enhancer-binding protein AP-2 is inhibited by SV40 T antigen
46. High levels of AP-2-binding activity in cell lines infected with human T-cell leukemia virus type I: Possible enhancement of AP-2 binding by human T-cell leukemia virus type I tax
47. Cloning and characterization of a second AP-2 transcription factor: AP-2β
48. Enhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-2β
49. Proteolytic activity in amyotrophic lateral sclerosis IgG preparations
50. A novel alternative spliced variant of the transcription factor AP-2α is expressed in the murine ocular lens
51. AP-2.2: A novel AP-2-related transcription factor induced by retinoic acid during differentiation of P19 embryonal carcinoma cells
52. Role of the proteasome and NF-κB in streptococcal cell wall-induced polyarthritis
53. The site of cAMP action in the insulin induction of gene expression of acetyl-CoA carboxylase is AP-2
54. Retinoid-induced apoptosis and Sp1 cleavage occur independently of transcription and require caspase activation
55. The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells
56. Lamin proteolysis facilitates nuclear events during apoptosis
57. TNF-induced signaling in apoptosis
58. CD95 (Fas)-induced caspase-mediated proteolysis of NF-κB
59. Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis
60. WAF-1 expression in human colorectal carcinoma: Association with p53, transcription factor AP-2 and prognosis
61. Genomic structure and DNA binding properties of the human zinc finger transcriptional repressor AP-2rep
62. Caspase-mediated cleavage of DNA topoisomerase I at unconventional sites during apoptosis
63. Transcription factor AP-2 essential for cranial closure and craniofacial development
64. Chicken transcription factor AP-2: Cloning, expression and its role in outgrowth of facial prominences and limb buds
65. Substrate specificities of caspase family proteases
66. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis
67. Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways
68. Proteolytic cleavage of beta-catenin by caspases: An in vitro analysis
69. Roles of caspases in apoptosis, development, and cytokine maturation revealed by homologous gene deficiencies
70. Cleavage of focal adhesion kinase by caspases during apoptosis
71. Cloning and expression of AP-2, a cell-type specific transcription factor that activates inducible enhancer elements
72. Analysis of the DNA-binding and activation properties of the human transcription factor AP-2
73. Chromosomal mapping of the human and mouse homologues of two new members of the AP-2 family of transcription factors
74. Developmental regulation of transcription factor AP-2 during Xenopus laevis embryogenesis
75. Phenylethanolamine N-methyltransferase gene expression: Synergistic activation by Egr-1, AP-2 and the glucocorticoid receptor
76. WAF1/CIP1 expression
77. Neural tube, skeletal and body wall defects in mice lacking transcription factor AP-2